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Protein import into the Leishmania glycosome requires docking of the cargo loaded peroxin 43 
5 (LdPEX5) receptor to the peroxin 14 (LdPEX14) bound to the glycosome surface. To 44 
examine the LdPEX14-membrane interaction, we purified L. donovani promastigote 45 
glycosomes and determined the phospholipid and fatty acid composition. These membranes 46 
contained predominately phosphatidylethanolamine, phosphatidylcholine, and 47 
phosphatidylglycerol modified primarily with C18 and C22 unsaturated fatty acid. Using 48 
large unilamellar vesicles (LUVs) with a lipid composition mimicking the glycosomal 49 
membrane in combination with sucrose density centrifugation and fluorescence activated 50 
cell sorting technique we established that the LdPEX14 membrane binding activity was 51 
dependent on a predicted transmembrane helix found within residues 149-179. Monolayer 52 
experiments showed that the incorporation of phosphatidylglycerol and phospholipids with 53 
unsaturated fatty acids, which increase membrane fluidity and favor a liquid expanded (LE) 54 
phase, facilitated the penetration of LdPEX14 into biological membranes. Moreover, we 55 
demonstrated that the binding of LdPEX5 receptor or LdPEX5-PTS1 receptor-cargo 56 
complex was contingent on the presence of LdPEX14 at the surface of LUVs.  57 
  58 
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Introduction 59 
Proteins destined for the glycosome matrix typically contain one of two major topogenic sequences 60 
designated peroxisomal targeting signal 1 (PTS1) [1-3] or peroxisomal targeting signal 2 (PTS2) 61 
[4]. These signal sequences are bound by the Leishmania receptor proteins peroxin 5 (PEX5) and 62 
peroxin 7 (PEX7) which selectively bind the PTS1 and PTS2 motifs, respectively, with nanomolar 63 
affinities [5, 6]. RNAi experiments in the closely related parasite Trypanosoma brucei showed 64 
deletion or knockdown of either PEX5 or PEX7 levels caused mistargeting of PTS1 and PTS2 65 
proteins, supporting the hypothesis that in kinetoplastid parasites both PEX5 and PEX7 are 66 
required for trafficking or translocation of cargo proteins into the glycosome [6-8].  67 
   A key component essential for the import of nascent polypeptides into glycosomes is 68 
LdPEX14. This protein is postulated to be part of a macromolecular complex proposed to form a 69 
convergence point to which the cargo loaded PEX5 and PEX7 receptors dock [9-14]. Although 70 
considerable advances have been made in identifying the machinery required for the trafficking 71 
and import of proteins into the glycosome, far less is known about the mechanisms that mediate 72 
association of proteins with the glycosome surface or translocation of large proteins across the 73 
glycosomal membrane. Accumulating evidence supports the notion that docking of cargo loaded 74 
PEX5 to the PEX14 containing importomer complex induces structural changes that promote the 75 
formation of a tightly gated channel or transient pore through which cargo proteins are postulated 76 
to pass [15-18].     77 
 Biophysical analysis showed that PEX14 in mammals, yeast (Hansenula polymorpha, Pichia 78 
pastoris) and trypanosomatids (Trypanosoma brucei), behaved as an integral membrane protein 79 
[7, 19-21]; whereas PEX14 from Leishmania donovani [22] and Saccharomyces cerevisiae [9] had 80 
characteristics typical of a peripheral membrane protein that is anchored to the  81 
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glycosome/peroxisome bilayer. Recent studies using recombinant L. donovani PEX14 (LdPEX14) 82 
illustrated that docking of L. donovani PEX5 (LdPEX5) induced conformational changes that 83 
involved a predicted transmembrane region spanning residues 149-179 of LdPEX14 [23], a 84 
domain that may be instrumental in the assembly of a translocation pore [15].   85 
 Here using biochemical and biophysical approaches we describe the phospholipid composition 86 
of the glycosomal membrane and demonstrate that the transmembrane domain on LdPEX14 is an 87 
important element mediating insertion of this protein into lipid bilayers that mimic the L. donovani 88 
glycosomal membrane. We show that membrane bound LdPEX14 is required for the association 89 
of LdPEX5 with LUVs but the LdPEX5-LdPEX14 interaction also promotes association of 90 
LdPEX5 with the lipid bilayer.  91 
 92 
 93 
Materials and methods 94 
 95 
Chemicals and reagents 96 
Restriction endonucleases and DNA-modifying enzymes were purchased from Invitrogen or New 97 
England Biolabs. Horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG was purchased 98 
from GE Healthcare. HRP-conjugated goat anti-mouse was purchased from Sigma-Aldrich. 99 
Synthetic phospholipids and cholesterol (Chl) were obtained from Avanti Polar Lipids. All other 100 
reagents were of the highest quality commercially available.   101 
 102 
Protein expression  103 
The L. donovani PEX14 coding sequence and the internal deletion mutant lacking amino acids 104 
149-179 (ldpex14149-179) was generated by PCR based mutagenesis using the C-terminal 105 
hexahistidine-tagged pET30-LdPEX14-His6. A fragment encompassing amino acids 120-200 of 106 
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LdPEX14 was amplified by PCR and cloned into the NdeI/XhoI sites of pET30b(+) to generate 107 
the pET30b-ldpex14 (120-200)-His6 expression construct. LdPEX14/ldpex14 proteins were 108 
expressed in E. coli strain ER2566 and purified as previously described [23], except for ldpex14 109 
(120-200) which was extracted from inclusion bodies prior to purification. LdPEX5 and ldpex5 110 
truncated proteins and the L. donovani PTS1 protein hypoxanthine-guanine 111 
phosphoribosyltransferase (LdHGPRT) were purified as previously described [23-25]. Purified 112 
proteins were concentrated and the buffer exchanged for 40 mM Tris-HCl pH 8.0 150 mM NaCl 113 
(TBS150) using an Amicon Ultra filter unit (Millipore). The protein concentration was measured 114 
spectrophotometrically at 280 nm by the method of Pace et al. [26]. Purified proteins were stored 115 
at -80 °C.   116 
 117 
Glycosome isolation  118 
Leishmania donovani promastigotes (1.0 x 1012 cells) grown in DME-L media containing 10% 119 
FBS were harvested, washed twice with 10 ml of cold PBS, twice with 10 ml of hypotonic buffer 120 
(HB) (25 mM HEPES pH 7.2, 2 mM EGTA and 2 mM DTT), and incubated on ice for 20 min 121 
prior to lysis by expulsion through a 26 gauge needle until 95% lysis was achieved, as assessed by 122 
phase contrast microscopy. Lysates were made isotonic and cellular debris and nuclei were 123 
removed by centrifugation at 5,000 x g for 10 min at 4 °C. The supernatant was then centrifuged 124 
at 45,000 x g for 40 min to obtain a crude organelle pellet. The crude organelle pellet was re-125 
suspended in 2.0 ml of 25 mM HEPES-NaOH, pH 7.4, applied to a 25-70% (w/v) sucrose gradient 126 
in 25 mM HEPES-NaOH pH 7.4, and then resolved by centrifugation at 125,000 x g for 16 h at 127 
4 °C in a Beckman-Coulter SW28 rotor. The gradient was fractionated and the protein 128 
concentration of each fraction determined using the micro BCA assay (Thermo-Fisher). Fractions 129 
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were analyzed for acid phosphatase activity using 5 mM p-nitrophenol phosphate in 50 mM 130 
sodium acetate (lysosome and plasma membrane) and by Western blot using anti-LdPEX14 or 131 
anti-aldolase (glycosomal), anti-cytochrome oxidase IV (mitochondria), anti-Bip (endoplasmic 132 
reticulum), and anti-tubulin (plasma membrane and flagella). Fractions enriched for LdPEX14 133 
were pooled, diluted four-fold with 25 mM HEPES, 150 mM NaCl and the organelle pellet 134 
collected by centrifugation at 45,000 x g for 1 h at 4 °C in a Beckman-Coulter Avanti JE centrifuge. 135 
The organelle pellet was re-suspended in 0.5 ml 25 mM HEPES, 150 mM NaCl and applied to a 136 
linear 20-40% Optiprep gradient in 25 mM HEPES 150 mM NaCl buffer and further resolved at 137 
125,000 x g for 1 h at 4 °C on a Beckman-Coulter SW41 rotor. The gradient was fractionated (0.75 138 
ml fractions) and analyzed using the above protocol. Fractions enriched for glycosomes were 139 
pooled and the purity evaluated by comparing the levels of LdPEX14 in 5 g of cell lysates, the 140 
45,000 x g pellet and supernatant and purified glycosomes.   141 
 142 
Lipid composition of the glycosomal membrane 143 
Phospholipids were extracted from purified glycosomes (300 g total protein) using the Folch 144 
extraction protocol [27]. Phospholipids were separated by two-dimensional thin layer 145 
chromatography on Silica-G plates (EMD Chemicals) using the mobile phases 146 
chloroform:methanol:ammonia:water (90:74:12:8) in the first dimension and 147 
chloroform:methanol:acetone:acetic acid:water (40:15:15:12:8) in the second dimension. 148 
Phospholipids were visualized by charring plates sprayed with 2.0 M sulfuric acid and spots were 149 
quantified by phosphate analysis [28] and compared with a standard mixture containing, 150 
dioleylphosphatidylcholine (DOPC), dioleylphosphatidic acid (DOPA), dioleoyl-151 
phosphatidylserine (DOPS), dioleoyl-phosphatidylethanolamine (DOPE), dioleoyl-152 
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phosphatidylglycerol (DOPG), bovine brain sphingomyelin, and bovine phosphatidylinositol (PI). 153 
Phospholipid spots were scraped, digested with perchloric acid for 1 h at 150 °C and the inorganic 154 
phosphate quantified by the Bartlett method [29]. 155 
 156 
Mass spectrometry analysis of phospholipids  157 
Phospholipid samples were suspended in chloroform/methanol (1:2 v/v) and analyzed by ESI-MS-158 
MS on an ABSciex 4000 QTrap (linear ion trap). Samples were loaded into thin-wall nanoflow 159 
capillary tips and analysed with capillary voltages between 1.0-1.5 kV for both negative and 160 
positive ion modes, tandem mass spectra (MS-MS) was used with nitrogen as collision gas and 161 
various collision offset energies to obtain precursor and neutral loss scans both in positive and 162 
negative ion mode and MS-MS daughter ions scans were conducted to confirm identification. 163 
 164 
Fatty acid composition of the glycosome phospholipids  165 
Glycosome phospholipids dissolved in hexane containing the internal standard 1,2-166 
diheptadecanoyl-sn-glycero-3-phosphoethanolamine (C17PE) (Avanti Polar Lipids) and sodium 167 
methoxide were incubated for 10 min at 20 °C [30]. Samples were extracted with hexane and 1 µl 168 
of the organic phase was injected onto a Varian CP-3800 gas chromatograph system equipped with 169 
a flame ionization detector, and a CP-Sil 88 capillary column (100 m x 0.25 mm, 0.20 µm film 170 
thickness, Varian). The injector and detector temperature were maintained at 260 °C and helium 171 
was used as the carrier gas while the oven temperatures was increased from 60 °C to 230 °C over 172 
a duration of 75 min. Methyl esters were identified by comparing retention times with a fatty acid 173 
methyl ester (FAME) standard mixture (Nu-Chek Prep, MN, USA). Quantification of the FAMEs 174 
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from C10 to C22:6 was calculated relative to the amount of the internal standard C17PE recovered 175 
using Galaxie software (Varian). 176 
 177 
Liposome preparation 178 
Individual phospholipids or mixtures of DOPE:DOPC:DOPG:PI:Chl (55:25:15:2.5:2.5; 179 
glycosome membrane mimetic mixture), DOPE:DOPC (2:1), DOPC:DOPG; (1:1), or 180 
DOPE:DOPG (1:1) were dissolved in chloroform and thin films were prepared by evaporation of 181 
the solvent under a nitrogen stream. Residual chloroform was removed under vacuum for 16 h. 182 
Multilamellar vesicles were prepared by re-suspending the lipid film in PBS at a concentration of 183 
5 mg/ml. The suspension was then extruded through a 0.2 m polycarbonate membrane 184 
(Millipore) to generate large unilamellar vesicles (LUV) with a diameter of 200 nm, a size 185 
comparable to Leishmania glycosomes [31].  186 
 187 
Sucrose density flotation centrifugation  188 
LUVs (500 g) were incubated with proteins (20 g of LdPEX14/ldpex14 variants or mixture of 189 
20 g of LdPEX14/ldpex14 variants and 15 g of LdPEX5/ldpex5 variants) in 300 µl of PBS for 190 
40 min at 25 °C, mixed with 1.2 ml of 66 % sucrose (w/v) in PBS, transferred to a 5.2 ml 191 
ultracentrifuge tube and overlaid with 3.0 ml of 40 % sucrose (w/v) in PBS, and then 1.0 ml of 192 
PBS. Samples were subjected to centrifugation at 75,000 x g for 16 h at 4 °C in a Beckman-Coulter 193 
SW55 rotor. The gradient was fractionated (0.65 ml/fraction) and the proteins were precipitated 194 
by the addition of sodium deoxycholate (0.2%), and trichloroacetic acid (15%). Protein pellets 195 
were acetone washed, resolved on SDS-PAGE sample buffer and proteins were visualized by 196 
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Western blot analysis using anti-LdPEX5 or anti-LdPEX14 rabbit antisera (1:5000) and goat anti-197 
rabbit horseradish peroxidase-conjugated secondary antibody (1:10000; Sigma-Aldrich). 198 
 199 
Alkaline carbonate extraction 200 
LUVs loaded with LdPEX5, LdPEX14, or ldpex14 (120-200) were isolated by flotation and treated 201 
sequentially with 500 mM NaCl, 100 mM Na2CO3 pH 11.5, and 100 mM Na2CO3 pH 11.5 202 
containing 4.0 M urea for 30 min at 0 °C [22]. Following each treatment samples were separated 203 
into a supernatant and pellet by centrifugation at 100,000 x g for 30 min at 4 °C in a TLA100.3 204 
rotor on a Beckman-Coulter table top ultracentrifuge. Proteins in the pellet and supernatant 205 
fractions were precipitated with 15% TCA and then analyzed by Western blot. 206 
 207 
Fluorescence Activated Cell Sorting (FACS) analysis  208 
Recombinant LdPEX5 (5.0 mg/ml) was labelled with Oregon Green 514 succinimidyl ester dye 209 
and LdPEX14 (5.0 mg/ml) was labelled with Bodipy 630/650 succinimidyl ester dye 210 
(ThermoFisher Scientific) using the protocols outline by the manufacturer. Labelled proteins were 211 
purified by passing the reaction mixture (100 l) through a 2.0 ml Sephadex G25 (0.8x4.0 cm) 212 
column and collecting the void volume fraction and protein concentrations measured 213 
spectrophotometrically [26]. The interaction of fluorescently tagged LdPEX5 and LdPEX14 with 214 
DOPE:DOPC:DOPG:PI:Chl LUVs was examined by pre-incubating alone or with 5 g of 215 
LdPEX5, 5 g of LdPEX14, or a mixture of 5 g of LdPEX5 and 5 g of LdPEX14 with 400 g 216 
of LUVs in 400 l of PBS for 15 min then diluting the sample to 2.0 ml with PBS for FACS 217 
analysis.  Analyses were performed on a BD FACSAria calibrated with 300 nm beads (Sigma-218 
Aldrich) and singlet LUV particles were gated on the basis of forward scatter height (FSC-H) 219 
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verses forward scatter area (FSC-A) on logarithmic scales. For LUV incubated with fluorescently 220 
tagged LdPEX5 and LdPEX14 the gates were determined to the LUV alone (negative control), 221 
and LUVs loaded with LdPEX14 exhibiting intermediate and high fluorescence intensities the 222 
gates were set arbitrarily based on the fluorescence of the two subpopulations.  223 
 224 
Langmuir monolayer interactions 225 
The binding of LdPEX14 to different phospholipid monolayers was performed on a Kibron 226 
DeltaPi-4 microtensiometer (Kibron Inc., Helsinki, Finland). The protein concentration required 227 
for surface saturation was determined using increasing protein concentration in the absence of 228 
phospholipids. Phospholipids were spread using a Hamilton syringe (Reno, NV, USA) at the 229 
surface of a trough containing 500 μl of 40 mM Tris HCl, 150 mM NaCl pH 7.8 buffer and the 230 
spreading solvent was allowed to evaporated until the surface pressure stabilized [32]. 231 
Measurements were performed with single phospholipid monolayers composed of DOPG, 232 
dimyristoyl phosphatidylglycerol (DMPG), palmitoyl-oleoyl phosphatidylglycerol (POPG) 233 
DOPE, DOPC, didocosahexaenoyl phosphatidylethanolamine (DDPE, 22:6) or a mixture of 234 
DOPE:DOPC:DOPG (55:25:20) or  DOPE:DOPC:DOPG:DDPE (47:25:20:8). LdPEX14 was 235 
injected into the subphase of the monolayers at different initial surface pressures (Πi) and the final 236 
surface pressure at equilibrium (Πe) was monitored as a function of time. Plots of ΔΠ (ΔΠ = Πe – 237 
Πi) as a function Πi permitted the calculation of MIP (maximum insertion pressure) II0 and synergy 238 
parameters [32, 33].  239 
 240 
Limited proteolysis 241 
Protein complexes in solution or bound to LUVs were re-suspended in 400 µl of PBS containing 242 
1.0 mM CaCl2 and 2.5 mM DTT then treated with clostripain (Worthington Biochemical Corp), at 243 
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a protease:substrate molar ratio of 1:50. The reaction was incubated at 0 °C and 75 µl aliquots 244 
were removed at 0, 2, 5 30, and 60 min time points.  Digest mixtures were treated with 1.0 ml of 245 
ice-cold acetone to precipitated proteins for Western blot analysis. Bands on Western blot were 246 
quantified by densitometry and analyzed using NIH ImageJ software [34].   247 
 248 
Bioinformatics 249 
Hydropathicity analysis for LdPEX14 was performed using Kyte and Doolittle algorithm [35] and 250 
a three dimensional model of ldpex14 (120-200) was generated using the I-TASSER ab initio 251 
modeling server (zhanglab.ccmb.med.umich.edu/I-TASSER) [36]. The capacity of this fragment 252 
to form a helix was determined using the Jufo9D program [37]. Both TOPCONS [38] and 253 
TMHMM [39] programs were used to predict the transmembrane propensity of the helical 254 
fragment identified by Jufo9D.  255 
 256 
 257 
Results 258 
Glycosome purification and phospholipid composition 259 
Using subcellular fractionation L. donovani promastigote glycosomes were ~20-fold enriched 260 
using a sucrose and Optiprep density gradient as previously described [6]. Crude glycosomes 261 
fractionated on a linear sucrose density gradient and screened for acid phosphatase activity showed 262 
that the fragments of plasma membrane or lysosome partitioned with fractions 2-10 (Fig. 1A). 263 
Western blot analysis using anti-LdPEX14, confirmed that glycosomes were predominantly 264 
recovered in fractions 20-25 near the bottom of the gradient (Fig. 1B). Similar analyses with anti-265 
cytochrome oxidase IV (COX IV) antibodies showed that mitochondria were predominantly 266 
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recovered in the 5,000 x g fraction. Analysis of the sucrose gradient fractions with the anti-COX 267 
IV and anti-tubulin antibodies showed minimal mitochondrial, plasma membrane, or flagella 268 
contamination of the glycosomes in fractions 20-25. Western blot analysis of pooled glycosomes 269 
collected from the Optiprep gradient using anti-LdPEX14 showed that glycosomes were ~20- and 270 
4-fold enriched when compared to whole cell lysate or the 45, 000 x g pellet, respectively (Fig. 271 
1C).  272 
 Analysis of the L. donovani glycosomal membrane phospholipid composition by 2D-TLC 273 
showed four major spots with a relative abundance of 52 ± 5%, 22 ± 4%, 16 ± 5%, 6 ± 2%, and 3 274 
± 1% based on phosphate determination (Table I, Fig 2A), which were identified as 275 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylglycerol (PG), and 276 
phosphatidylinositol (PI) and inositol-phosphocermide (IPC) using the phospholipid standard 277 
mixture containing DOPC, DOPE, DOPS, DOPA, DOPG, phosphoinositol and sphingomyelin. 278 
This revealed that the Leishmania glycosomal membrane had an ~8-fold higher 279 
phosphatidylglycerol content (Table I) when compared to the plasma membrane composition (16% 280 
vs 2%) [40]. 281 
 282 
 Electrospray mass spectrometry (ESI-MS/MS) analysis of the glycosome phospholipids using 283 
both positive and negative ion modes confirmed the presence of five major classes of 284 
phospholipids: phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidylglycerol 285 
(PG), phosphatidylinositol (PI) and inositol-phosphoceramide (IPC) (Fig. 2B & 2C). Mass 286 
spectrometry analysis also detected the presence of sphingolipid ceramide that was not resolved 287 
as with the solvent systems used for the 2D-TLC analysis as this lipid is predicted to migrate with 288 
the solvent front.  289 
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 Fatty acid analysis by gas chromatography revealed that ~60% of the fatty acid content of the 290 
glycosomal membrane phospholipids was 18-carbon long fatty acid chains (C18), with the 291 
unsaturated fatty acids C18:1 and C18:2 being the most abundant (Table II). In addition, the L. 292 
donovani glycosomal membrane contained significant amounts of the longer chain C22:5 fatty 293 
acid (~15% of total fatty acids). Interestingly, ~47% of the fatty acid content of these phospholipids 294 
was polyunsaturated (Table II), a feature that contributes to an increased membrane fluidity [41].  295 
 296 
LdPEX14-membrane interaction  297 
Sucrose density flotation experiments were performed using LUVs mimicking the L. donovani 298 
glycosomal membrane phospholipid composition to evaluate the LdPEX14-membrane interaction. 299 
Incubation of LdPEX14 with DOPE:DOPC:DOPG:PI:Chl LUVs showed that a significant portion 300 
of the recombinant protein bound to these model membranes floated to the top of the sucrose 301 
gradient (Fig. 3A). In the absence of LUVs, no LdPEX14 flotation was observed. Addition of 500 302 
mM NaCl, a salt concentration typically used to disrupt electrostatic interactions with the 303 
membrane surface, did not alter the binding of LdPEX14 to LUVs. This suggested that the 304 
LdPEX14-membrane association was stabilized by hydrophobic contacts with the lipid bilayer 305 
core (Table I, Fig. 3A). Interestingly, incubating LdPEX14 with LUVs at 0 °C or 23 °C prior to 306 
flotation revealed that ~50-70% of LdPEX14 was recruited to the LUV membranes; whereas at 307 
37 °C, near quantitative binding of LdPEX14 to LUVs was obtained (Fig. 3B). 308 
 LUVs loaded with LdPEX14 and purified by sucrose flotation were sequentially extracted with 309 
500 mM NaCl and 100 mM alkaline carbonate, treatments used to evaluate the membrane-protein 310 
interaction. In both cases LdPEX14 partitioned with the LUV membrane pellet, a biophysical 311 
behaviour diagnostic of a protein forming contacts with the hydrophobic core the lipid bilayer (Fig. 312 
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3C). A more stringent extraction of the LUV membrane pellet with 100 mM alkaline carbonate 313 
containing 4.0 M urea resulted in an equal distribution of LdPEX14 between the supernatant and 314 
membrane pellet fraction (Fig. 3C), further supporting the conjecture that this interaction was 315 
stabilized by nonpolar contacts [42].  316 
 To examine if membrane association altered the LdPEX14 structure, a limited proteolytic 317 
analysis was performed using the arginine specific endoproteinase clostripain. In the absence of 318 
LUVs LdPEX14 exhibited a high susceptibility to proteolytic cleavage and was complete degraded 319 
within 5 min (Fig. 3D). In contrast, membrane bound LdPEX14 exhibited a marked resistance to 320 
proteolysis and resulted in ~50 % of the full length LdPEX14 remaining after a 30 min incubation 321 
and is suggestive of a membrane insertion which triggers structural changes that render LdPEX14 322 
more resistant to proteolysis (Fig. 3D). It should be noted that some degradation of LdPEX14 was 323 
detected in these Western blots. This is attributed to the extreme susceptibility of this protein to 324 
proteolysis arising from its predicted native disordered structure (unpublished data). 325 
  326 
The hydrophobic region of LdPEX14 is required for membrane attachment  327 
A hydropathicity analysis of the LdPEX14 protein revealed that a region spanning residues 120-328 
200 (Fig. 4A & 4B) contained a putative transmembrane helix (residues 154-174) (Fig. 4A, solid 329 
line) circumscribed by a proline rich random coil region (residues 120-152) corresponding to the 330 
Leishmania PEX7 binding site [6], and an arginine rich region (residues 182-200, highlighted in 331 
red) located downstream of the putative transmembrane helix, a structure known to have 332 
membrane binding activity [43]. Ab initio modeling of residues 154-174 using the I-TASSER 333 
algorithm indicated that this region favors a helical structure spanning 15 amino acids and 334 
measuring 22.4 Å in length (α-carbon to α-carbon) (Fig. 4C).  335 
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Additionally, intrinsic fluorescence measurements using W152 from ldpex14(120-200) as an 336 
environmental probe showed a strong hypsochromic shift in the maximum wavelength of 337 
fluorescence emission of W152 indicating that this region inserts into the hydrophobic 338 
environment of the lipid bilayer (Fig. S1A). Likewise, acrylamide quenching experiments revealed 339 
higher quenching constants (dynamic component: 9.6 M-1, static component: 0.8 M-1) in the 340 
absence of liposomes whereas a Stern-Volmer constant of 3.0 M-1 was observed in the presence 341 
of liposomes (Fig. S1B and S1C), indicating that W152 was more accessible to quenching in the 342 
absence of liposomes. 343 
 To verify that this hydrophobic region was required for membrane association, an internal 344 
deletion mutant lacking residues 149-179 (ldpex14Δ149-179) was generated and membrane 345 
binding assessed by sucrose density flotation. Unlike the full length LdPEX14, which exhibited 346 
robust binding to DOPE:DOPC:DOPG:PI:Chl LUVs (Fig. 5A), no interaction of ldpex14Δ149-347 
179 with LUVs was detected. This observation supports the notion that residues 149-179 formed 348 
a structural element required for membrane association (Fig. 5A). To validate this hypothesis a 349 
recombinant protein fragment encompassing residues 120-200 (ldpex14 (120-200)) generated and 350 
assayed for membrane binding activity. The ldpex14 (120-200) fragment was found to 351 
quantitatively bind the glycosome mimetic LUVs (Fig. 5A).  352 
 353 
Anionic phospholipids are required for LdPEX14 membrane binding  354 
The role of the phospholipid composition of lipid bilayers in mediating the LdPEX14-membrane 355 
interaction was examined using liposomes composed of the single phospholipids DOPC, DOPG, 356 
or DOPS or a mixture of DOPE:DOPC, DOPC:DOPG, and DOPE:DOPG or hexagonal phase II 357 
structures composed of DOPE or DOPA. Sucrose density flotation experiments showed a robust 358 
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binding and flotation of LdPEX14 associated with DOPA, DOPG, DOPS, DOPC:DOPG (1:1) and 359 
DOPE:DOPG (1:1) vesicles (Fig. 5B). However, no significant binding was detected with DOPC, 360 
DOPE, or DOPE:DOPC (2:1) phospholipid (Fig. 5C) which suggested that anionic phospholipids 361 
were required for LdPEX14 association with lipid bilayers.  362 
 Fluorescence activated cell sorting (FACS) was used as a second independent method to 363 
corroborate the LdPEX14-LUV interaction. For this technique, LdPEX5 and LdPEX14 were 364 
labelled with the fluorescent dyes Oregon Green and Bodipy 630/650, respectively, then mixed 365 
with LUVs and analyzed by flow cytometry. PEX-free LUVs displayed low autofluorescence in 366 
both channel used (Fig. 6A), as expected. Oregon Green-labelled LdPEX5 alone failed to bind to 367 
LUVs, as determined by the arguably small increase in fluorescence detected on the LUVs (Fig. 368 
6B). In stark contrast, LUVs incubated with LdPEX14 tagged with Bodipy 630/650 fluorescent 369 
dye segregated two LUV populations with intermediate (~58% of LUVs) and high fluorescence 370 
intensities (~16%). The variation in the fluorescence intensities likely corresponds to difference in 371 
the number of LdPEX14 molecules bound to per LUV (Fig. 6C). Addition of Oregon Green 372 
tagged-LdPEX5 to LUVs loaded with LdPEX14 resulted into additional subpopulations of LUVs 373 
with intermediate (~22%) and high fluorescence intensities (~9%) that contain both LdPEX5 and 374 
LdPEX14 (Fig. 6D). These results also confirm that the association of LdPEX5 with the LUVs is 375 
dependent LdPEX14. 376 
 377 
Insertion of LdPEX14 into phospholipid monolayers  378 
To investigate the effect of the phospholipid head groups and lipid packing on LdPEX14 insertion 379 
into membranes, experiments were performed using monolayers of defined phospholipid 380 
composition as previously described [32, 33, 44]. Prior to these experiments, the surface binding 381 
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activity of LdPEX14 or ldpex14149-179 was assessed by monitoring the increase in surface 382 
pressure at the air-buffer interface as a function of protein concentration [44].  As shown in Figure 383 
7A, saturation of the air-buffer interface was observed when 0.31 M of LdPEX14 was added to 384 
the subphase, which resulted in a maximum pressure of 23.9 mN/m. In contrast, saturation of the 385 
air-buffer surface with ldpex14149-179 was observed using a protein concentration of ~0.86 M 386 
at a lower pressure of 21.2 mN/m (Fig. 7A). In addition, the kinetics of LdPEX14 binding is much 387 
faster than that of LdPEX14-Δ49-179 (Fig. 7B). Altogether, these data suggest that LdPEX14 has 388 
a much larger surface activity than LdPEX14-Δ149-179, thus highlighting the importance of the 389 
transmembrane segment of LdPEX14 in its membrane binding. The additional measurements were 390 
thus solely performed using LdPEX14. The impact of phospholipid head groups on LdPEX14 391 
membrane interaction was examined using monolayers with increasing lateral initial surface 392 
pressure (i), which reflects the degree of lipid packing [32, 33, 44, 45], and the change in surface 393 
pressure () was monitored following injection of 0.31 M LdPEX14 into the subphase. Linear 394 
regression plots of  versus i permitted determination of the maximum insertion pressure (MIP) 395 
at which LdPEX14 would penetrate into lipid monolayer and the synergy factor (Fig. 7C) which 396 
provides a measure of the affinity of LdPEX14 for the lipid monolayer [32, 33].  397 
 Monolayers composed of DOPG, DOPC, and DOPE, lipids with a similar phase transition 398 
temperature of -16 to -18 °C [46], showed that DOPG monolayers exhibited the highest MIP 399 
following LdPEX14 insertion into the monolayers (Fig. 8A). The synergy factor, an indicator of 400 
the favourability of the interaction between a protein and phospholipid monolayer (Fig. 8B), also 401 
confirmed that the DOPG monolayer had greatest affinity for LdPEX14, an observation supported 402 
by LUV binding using sucrose density flotation experiments (Fig. 5B). Similarly, the rate of 403 
absorption was higher for DOPG (Fig. S2). In addition, the lowest values of MIP and synergy have 404 
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been obtained with DOPE, which is also consistent with the measurements performed using LUVs 405 
(Fig. 5B). 406 
 To study the interaction of LdPEX14 with membranes that mimic the composition of the 407 
glycosomal membrane, mixed monolayers containing DOPE:DOPC:DOPG (55:25:20) were used. 408 
Surprisingly, the values of MIP and synergy parameters for mixed monolayers were significantly 409 
smaller than those obtained with monolayers containing only DOPG (Fig. 8A & 8B). However, an 410 
interesting feature of the glycosomal membrane was the high proportion of unsaturated long chain 411 
C22 fatty acids (Table I). Incorporating the phospholipid DDPE containing the long chain C22:6 412 
fatty acid into mixed monolayers with composition DOPE:DOPC:DOPG:DDPE (47:25:20:8) 413 
showed enhanced LdPEX14 binding as reflected by the increase in the MIP and synergy values 414 
(Fig. 8A & 8B); albeit the value of synergy is lower values then observed with DOPG monolayers. 415 
 The latter experiment suggested that the degree of fatty acid unsaturation and monolayer 416 
fluidity both influenced LdPEX14 binding. To test this hypothesis monolayers composed of 417 
DMPG, POPG, or DOPG; phospholipids with liquid crystalline to solid crystalline gel phase 418 
transition temperature of 23 °C, -1 °C, and -18 °C, respectively [46], were prepared and LdPEX14 419 
insertion was monitored. Monolayer composed of DMPG and POPG, which at 20 °C have reduced 420 
fluidity, exhibited lower MIP and synergy values when compared to DOPG monolayers (Fig. 8C 421 
& 8D). These data indicate that lipid packing has an impact on LdPEX14 insertion into membranes 422 
and an increased fluidity favors the insertion of LdPEX14. 423 
  424 
LdPEX14 is required for LdPEX5 association with LUVs  425 
LdPEX14 is proposed to function as a docking complex that facilitates the binding of cargo loaded 426 
LdPEX5 receptor to the glycosome surface. To validate this model, glycosome mimetic LUVs 427 
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alone or loaded with LdPEX14 were used. Addition of LdPEX5 or the LdPEX5-PTS1 complex to 428 
DOPE:DOPC:DOPG:PI:Chl LUVs showed that this receptor alone or loaded with the PTS1 cargo 429 
protein LdHGPRT (PTS1) [47] showed not binding to LUVs (Fig. 9A & 9B). Similarly, no binding 430 
was detected when LdHGPRT (PTS1) alone was added to LUVs loaded with LdPEX14 (Fig. 9C). 431 
However, addition of LdPEX5 or LdPEX5-PTS1 to LUVs charged with LdPEX14 resulted in 432 
robust binding of LdPEX5 and LdHGPRT to LUVs (Fig. 9D & 9E). These data confirm that the 433 
recruitment of LdPEX5 is dependent on its association with membrane bound LdPEX14 since no 434 
LdPEX5 binding was detected with LUVs loaded ldpex14 (149-179) (Fig. 9F), a variant 435 
LdPEX14 that is known to bind LdPEX5 in solution [23], but not LUVs mimicking the glycosomal 436 
membrane (Fig. 5A). 437 
 Previous studies reveal that in solution LdPEX5-LdPEX14 interaction was depend on the 438 
W293 AQEY297 motif on LdPEX5 [48, 49]. To evaluate if this motif was required for the association 439 
of LdPEX5 with LUV bound LdPEX14, sucrose density flotation experiment were performed by 440 
mixing LdPEX5 or ldpex5 N-terminal truncation constructs with LUVs in the presence and 441 
absence of LdPEX14. It should be noted that none of the ldpex5 N-terminal truncation constructs 442 
lacking the first 205 residues (ldpex5 (205-625)), 268 residues (ldpex5 (268-625)) or 303 residue 443 
(ldpex5 (303-625)) or the internal ldpex5 fragment spanning residues 203-391 (ldpex5 (203-391)) 444 
alone bound to the DOPE:DOPC:DOPG:PI:Chl LUVs. Western blot analysis demonstrated that 445 
the latter ldpex5 proteins were all detected at the bottom of the sucrose density gradient (Fig. 10A). 446 
However, in the presence of LdPEX14 bound to LUVs, ldpex5 (205-652), ldpex5 (268-625) and 447 
the internal fragment ldpex5 (203-391) all floated and were at the top of the sucrose gradient (Fig. 448 
10A, right panel). In contrast, no flotation of the N-terminal truncation variant ldpex5 (303-625) 449 
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was observed. This is likely due the absence of the region required for the interaction with 450 
LdPEX14. 451 
 To examine the association of the LdPEX5-LdPEX14 complex with membranes, LdPEX14 452 
or LdPEX5-LdPEX14 loaded LUVs purified by sucrose density flotation centrifugation were 453 
sequentially extracted with NaCl, alkaline carbonate, and alkaline carbonate/urea (Fig. 3C).  454 
However, similar extractions of LUVs loaded with LdPEX5-LdPEX14 revealed that >90% of the 455 
LdPEX14 was retained in the membrane pellet (Fig. 10B). The data suggest that the binding of 456 
LdPEX5 alters the interaction of LdPEX14 with the lipid bilayer which increases the hydrophobic 457 
contacts with the membrane.  More surprisingly was the observation that LdPEX5, a soluble 458 
protein without a predicted transmembrane domain, remained highly refractory to alkaline 459 
carbonate/urea extraction. It is likely that the LdPEX5-LdPEX14 interaction is extremely stable 460 
and resistant to alkaline carbonate/urea treatment [48, 49].  In contrast to LdPEX5, which requires 461 
LdPEX14 for membrane interaction, the mammalian and yeast PEX5 alone were sufficient for 462 
membrane insertion [15, 17, 50].  463 
 464 
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Discussion 465 
PEX14 is a vital biogenesis component required for the docking/translocation machinery that 466 
participates in formation of a dynamic pore that mediates the import of folded proteins or protein 467 
complexes across the glycosome/peroxisome membrane [7, 9, 12, 13, 15, 51-53]. Native LdPEX14 468 
isolated from glycosomes is part of an ~800 kDa complex that is anchored as a peripheral 469 
membrane protein to the cytosolic face of the glycosomal membrane [23, 54]. Lipidomic analysis 470 
of the L. donovani glycosome revealed that this organellar membrane contained elevated levels of 471 
phosphatidylethanolamine and phosphatidylglycerol (Table I); phospholipids with a small head 472 
group that would impart a lower lateral membrane pressure and confer an anionic charge on these 473 
membranes [55]. Moreover, fatty acid analysis showed that that phospholipids of the glycosomal 474 
membrane, and in particular phosphatidylglycerol, were preferentially modified with 475 
polyunsaturated C18 and C22 fatty acids; fatty acids that are enriched in Leishmania [56]. 476 
Collectively, the physiochemical properties of the phospholipids of glycosome membrane are 477 
predicted to increase the membrane fluidity which would facilitate mobility and structural 478 
rearrangement of proteins in the bilayer [57, 58]; features that may be critical for LdPEX14 479 
insertion, oligomerization, and transient pore formation on the glycosomal membrane [59]. This 480 
conjecture is further supported by experiments in this study showing that incorporation of DOPG 481 
(C18:1) and DDPE  (C22:6) into monolayer favored an increase in the maximum insertion pressure 482 
and synergy factor [33] associated with the insertion of LdPEX14. In contrast, the mammalian, 483 
yeast, and T. brucei peroxisomal/glycosomal membranes have lipid compositions enriched in 484 
phosphatidylcholine and the negatively charged lipid phosphatidylinositol [60-62], which may 485 
influence the interaction of the PEX14 homologues with these membranes.  486 
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 Binding studies performed using sucrose density flotation or FACS techniques both 487 
corroborated the hypothesis that recombinant LdPEX14 can spontaneously insert into model 488 
membranes that mimic the composition of the Leishmania glycosome. This association was 489 
critically dependent on residues 149-179, a segment calculated to adopt a hydrophobic 490 
transmembrane -helix. Smaller fragments of ldpex14 that encompass residues 120-200 also 491 
spontaneously bound to LUVs.  492 
  Monolayer experiments confirmed that the phospholipid head groups had a profound influence 493 
on membrane insertion, with DOPG dramatically favoring LdPEX14 penetration into biological 494 
membranes as reflected by the MIP and synergy parameters. Incorporating even modest levels of 495 
DOPG, ~20 mole percent, into mixed membranes, levels comparable to those detected in the 496 
glycosomal membrane was sufficient to promote LdPEX14 insertion. In contrast, monolayer 497 
composed of DOPE or DOPC exhibited a diminished LdPEX14 insertion activity which suggests 498 
that negatively charged lipids are important for recruiting LdPEX14 to biological membrane. This 499 
contention is further supported by the observation that high salt concentrations caused a marked 500 
decrease in the synergy values. The synergy values of ~0.35 suggest that LdPEX14 insertion is 501 
favored with lipid bilayers in a liquid crystalline state [45] such as the glycosomal membrane 502 
which contains a high content of unsaturated fatty acids. Increased membrane fluidity is likely to 503 
be critical for the dynamic recruitment, insertion, and structural rearrangements of proteins 504 
associated with the formation of the transient translocation pore on the glycosomal membrane.  505 
 A key event in the import of proteins into the glycosome matrix involves the formation of a 506 
transient pore following the docking of the LdPEX5 receptor loaded with a PTS1 cargo to the 507 
glycosome-associated LdPEX14 [15, 63].  Here we demonstrated using sucrose density flotation 508 
and FACS experiments that the binding of LdPEX5, to LUVs was critically dependent on the 509 
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presence of LdPEX14 bound to the vesicle membrane. Interestingly, extraction of LUVs loaded 510 
with the LdPEX5-LdPEX14 complex, using stringent conditions that included both alkaline 511 
carbonate and 4 M urea suggested that following recruitment LdPEX5 inserted into the lipid 512 
bilayer where it is postulated to participate in the formation of a transient pore [16, 64]. However, 513 
since LdPEX5 does not contain any predicted transmembrane domains it is likely that this protein 514 
does not form direct contacts with the lipid bilayer but remains tightly associated with the 515 
membrane bound LdPEX14 [48, 49, 65]. Truncation mapping studies confirmed that the binding 516 
of LdPEX5 with LUV bound LdPEX14 was depend on residues 268-303, a region containing a 517 
WAQEY motif that binds LdPEX14 with a low nanomolar affinity [48]. Finally, the studies provide 518 
a framework required to dissect the protein-membrane interactions and the molecular events 519 
associated with the binding of PTS1 and PTS2 loaded receptors to the LdPEX14 containing 520 
complex and subsequent transient pore formation on the glycosome mimetic membranes. 521 
 522 
523 
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 747 
Table I. Phospholipid composition glycosomal/peroxisomal membranes 748 
Phospholipid PC PE PG PS PI PA CL Reference 
R. norvegicus 61 30 - 3 5 - - [61] 
S. cerevisiae 48 23 - 4 16 2 7 [62] 
T. brucei 61 13 - 7 19 - - [66] 
L. donovani 52 25 15 - 8* - - This study 
* This includes IPC. 749 
 750 
 751 
 752 
 753 
 754 
 755 
 756 
Table II Fatty acid composition of the 757 
L. donovani glycosomal membrane 758 
Fatty acid % of total 
C14:0 2.8 ± 0.1 
C16:0 7.1 ± 0.7 
C17 0.8 ± 0.2 
C18:0 12.8± 0.3 
C18:1 25.5± 1.3 
C18:2 17.9 ± 0.4 
C18:3  6.9 ± 0.1 
C19- cyclopropyl 2.8 ± 0.5 
C20:2 0.9 ± 0.1 
C20:4 0.7 ± 0.2 
C22:2 1.2 ± 0.3 
C22:4 4.5 ± 0.2 
C22:5 14.5 ± 0.3 
C22:6 1.7 ± 0.2 
C24:0 2.1 ± 0.7 
Analysis was performed in triplicate.  759 
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Figure legends 760 
Fig. 1. Purification of L. donovani glycosomes.  761 
(A) Isolation of glycosomes from L. donovani promastigotes was performed by layering the 45,000 762 
x g organelle pellet onto a 25-70% (w/v) sucrose gradient and resolving organelles by 763 
centrifugation, fractionated from the top and the protein concentration and acid phosphatase 764 
activity determined. (B) Aliquots of the whole cell lysate (lysate), 5,000 x g nuclear pellet (nuclei), 765 
45,000 x g supernatant (45k gS) and 45,000 x g pellet (45k gP) and sucrose gradient fractions were 766 
resolved by SDS-PAGE and Western blot performed using anti-LdPEX14 (glycosome), anti-COX 767 
IV (mitochondria), anti-Bip (endoplasmic reticulum), and anti-tubulin (plasma membrane or 768 
flagella). (C) Enrichment of glycosomes isolated from the Optiprep gradient was assessed using 5 769 
g of purified glycosomes (glycosomes), 45,000 x g organelle pellet (45k gP), and whole cell 770 
lysate (lysate) and blots were sequentially probed with anti-LdPEX14 and anti-aldolase, and anti-771 
tubulin.  772 
 773 
Fig. 2. Lipidomic analysis of L. donovani glycosomal membrane.  774 
(A) Phospholipids extracted from purified glycosomes were resolved by 2D-TLC on Silica G thin 775 
layer chromatography plates and spots were visualized by charring with sulfuric acid. Analysis of 776 
the phospholipid classes and fatty acid modifications were determined by electrospray ionization 777 
mass spectroscopy (ESI-MS/MS) and survey scans were obtained in (B) negative ion mode to 778 
characterize phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatylinositol (PI) 779 
and inositol-phosphoceramide (IPC) lipids and (C) positive ion mode to identify 780 
phosphatidylcholine (PC) lipids.   781 
 782 
Fig. 3. Interaction of LdPEX14 with large unilamellar vesicles (LUVs).  783 
(A) LdPEX14 binding to LUVs was assessed at 20 °C in the absence (NL) or the presence of 150 784 
or 500 mM NaCl prior to flotation on a sucrose density gradient. (B) The effect of temperature on 785 
membrane binding was assessed by pre-incubating LdPEX14 with LUVs at 0, 23 or 37 °C for 40 786 
min prior to density flotation centrifugation and Western blot analysis. (C) The interaction of 787 
LdPEX14 with the lipid bilayers was examined by sequential extraction of LdPEX14 loaded LUVs 788 
with 500 mM NaCl, 100 mM alkaline carbonate and 100 mM alkaline carbonate / 4.0 M urea. 789 
Extracts were separated into supernatant (S) and pellet (P) by centrifugation at 100,000 x g prior 790 
to Western blot analysis with anti-LdPEX14 antibodies. (D) The association of LdPEX14 with the 791 
lipid bilayer was examined using the protease clostripain treatment in the absence (NL) or presence 792 
(L) of LUVs. Band intensities were quantified using the ImageJ software. 793 
 794 
Fig. 4. Analysis of the LdPEX14 hydrophobic domain.  795 
(A) Secondary structure and transmembrane topology predictions of ldpex14 (120-200) were 796 
performed using the Jufo9D, I-TASSER 5.1, TMHHM 2.0 and TOPCONS2 programs. E denotes 797 
extended strands, H alpha-helix and C random coils; o denotes outside face the membrane, M 798 
transmembrane and i inside face of the membrane (B) Hydrophobicity analysis was predicted by 799 
the Kyte and Doolittle (solid line) algorithm [38]. (C) I-TASSER in silico model of the LdPEX14 800 
residues 154-174 is predicted to adopt a helical structure with a helix length of 22.4 Å, sufficient 801 
to span a lipid bilayer.  Molecular graphics were performed using the PyMOL software (v1.8.6).  802 
 803 
Fig. 5. The hydrophobic domain and anionic phospholipids are required for membrane binding.  804 
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(A) LdPEX14, ldpex14 (Δ149-179), or ldpex14 (120-200) were incubated with and without 805 
DOPE:DOPC:DOPG:PI:Chl (55:25:15:2.5:2.5) LUVs, resolved by sucrose density flotation and 806 
the distribution of LdPEX14 and ldpex14 (Δ149-179) assessed by Western blot analysis using anti-807 
LdPEX14 or anti-His6 (ldpex14 120-200). (B) LdPEX14 was incubated with LUVs prepared with 808 
the single phospholipids DOPC, DOPE, DOPA, DOPG or DOPS or (C) a mixture of DOPE:DOPC, 809 
DOPC:DOPG, or DOPE:DOPG for 40 min at 20 °C then resolved by sucrose density 810 
centrifugation.    811 
 812 
Figure 6: Fluorescence Activated Cell Sorting (FACS) analysis of LdPEX5 and LdPEX14 with 813 
LUVs. DOPE:DOPC:DOPG:PI:cholesterol (55:25:15:2.5:2.5) 200 nm LUVs (400 g) prepared 814 
by extrusion were incubated in PBS (A) or with Oregon Green tagged LdPEX5 (5 g) (B), Bodipy 815 
630/650 tagged LdPEX14 (5 g) (C), or a mixture of fluorescently tagged LdPEX5 (5 816 
g)/LdPEX14 (5 g) (D), and the bound proteins were analyzed on a BD FACSAria instrument. 817 
Gates were established as described in the Experimental procedures section and the percent 818 
distribution of the LUV populations are given in the top right hand corner of each panel.  819 
 820 
Fig. 7. Interaction of LdPEX14 with lipid monolayers.  821 
(A) Determination of ∆Π0, maximum insertion pressure (MIP) and synergy on a monolayer of 822 
DOPG for LdPEX14. (B) Determination of the superficial pressure and the saturating 823 
concentration of the air-buffer interface for LdPEX14 (circles) and ldpex14(∆149-179) (squares) 824 
in the absence of phospholipids. (C) Representative raw plots of the evolution of the superficial 825 
pressure (Π) over time, upon addition of lipids (DOPG in this case) and protein (final protein 826 
concentration : 150 nM for LdPEX14 (black line), 250 nM for ldpex14Δ149-179 (red line)). 827 
Dotted lines were added manually to illustrate the rate of penetration of the protein into the 828 
phospholipid monolayer. 829 
 830 
Fig. 8.  831 
Binding parameters of LdPEX14 to monolayers of different phospholipids.  832 
(A) Maximum insertion pressure and (B) synergy of binding of LdPEX14 to monolayers of 833 
different phospholipids. (C) Maximum insertion pressure, (D) synergy of attachment of LdPEX14 834 
to monolayers of PG phospholipids containing different fatty acid chains.  835 
 836 
Fig. 9. LdPEX14 promotes membrane binding of LdPEX5 and LdHGPRT.  837 
LUVs were incubated with (A) LdPEX5 or LdHGPRT (PTS1) individually, (B) LdPEX5- 838 
LdHGPRT complex, (C) a mixture of LdPEX14 and LdHGPRT, (D) a mixture of LdPEX14 and 839 
LdPEX5, (E) mixture of LdPEX14 and an LdPEX5-LdHGPRT complex or (F) with a mixture of 840 
ldpex14 149-179 and LdPEX5. Reaction mixtures were resolved by sucrose density flotation 841 
centrifugation and the distribution of proteins in the gradients assessed by Western blot analysis 842 
anti-LdPEX14 (1:10,000), anti-LdPEX5 (1:10,000) and anti-LdHGPRT (1:2,000) specific 843 
antisera.  844 
 845 
Figure 10. Membrane insertion of LdPEX5 in LdPEX14 loaded LUVs.   846 
(A) The LdPEX5 motif required for the binding of LUV bound LdPEX14 was localized by mixing 847 
ldpex5 variant encompassing residues 205-625 (ldpex5 (205-625)), 268-625 (ldpex5 (268-625)), 848 
303-625 (ldpex5 (303-625)), or 203-391 (ldpex5 (203-391) with LUVs in the presents or absence 849 
of LdEX14. (B) LdPEX14 and LdPEX5 were purified by sucrose density flotation. LUVs were 850 
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sequentially extracted with 500 mM NaCl, alkaline carbonate pH 11.5, and alkaline carbonate 851 
containing 4.0 M urea for 30 min at 0 °C.  Following each treatment, samples were separated into 852 
supernatant (S) and membrane pellet (P) fractions by centrifugation at 100,000 x g for 30 min at 853 
4 °C and the protein distribution examined by Western blots.  854 
 855 
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 Figure 8: 1006 
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